TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

E Kabashi, PN Valdmanis, P Dion, D Spiegelman… - Nature …, 2008 - nature.com
Recently, TDP-43 was identified as a key component of ubiquitinated aggregates in
amyotrophic lateral sclerosis (ALS), an adult-onset neurological disorder that leads to the …

Increased exonic de novo mutation rate in individuals with schizophrenia

…, S Zhou, L Jouan, A Dionne-Laporte, D Spiegelman… - Nature …, 2011 - nature.com
Schizophrenia is a severe psychiatric disorder that profoundly affects cognitive, behavioral
and emotional processes. The wide spectrum of symptoms and clinical variability in …

De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia

…, L Xiong, D Spiegelman… - Proceedings of the …, 2010 - National Acad Sciences
Schizophrenia likely results from poorly understood genetic and environmental factors. We
studied the gene encoding the synaptic protein SHANK3 in 285 controls and 185 …

Novel de novo SHANK3 mutation in autistic patients

J Gauthier, D Spiegelman, A Piton… - American Journal of …, 2009 - Wiley Online Library
A number of studies have confirmed that genetic factors play an important role in autism
spectrum disorder (ASD). More recently de novo mutations in the SHANK3 gene, a synaptic …

[HTML][HTML] De Novo Mutations in Moderate or Severe Intellectual Disability

…, C Massicotte, A Ambalavanan, D Spiegelman… - PLoS …, 2014 - journals.plos.org
Genetics is believed to have an important role in intellectual disability (ID). Recent studies
have emphasized the involvement of de novo mutations (DNMs) in ID but the extent to which …

[PDF][PDF] Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability

…, K Higashi, AR Park, D Spiegelman… - The American Journal of …, 2011 - cell.com
Little is known about the genetics of nonsyndromic intellectual disability (NSID). We
hypothesized that de novo mutations (DNMs) in synaptic genes explain an important fraction of …

[PDF][PDF] High rate of recurrent de novo mutations in developmental and epileptic encephalopathies

…, CT Myers, P Cossette, P Lemay, D Spiegelman… - The American Journal of …, 2017 - cell.com
Developmental and epileptic encephalopathy (DEE) is a group of conditions characterized
by the co-occurrence of epilepsy and intellectual disability (ID), typically with developmental …

[HTML][HTML] Mutations in SYNGAP1 in Autosomal Nonsyndromic Mental Retardation

FF Hamdan, J Gauthier, D Spiegelman… - … England Journal of …, 2009 - Mass Medical Soc
<p id="p001">Although autosomal forms of nonsyndromic mental retardation account for the
majority of cases of mental retardation, the genes that are involved remain largely unknown. …

Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia

…, N Champagne, M Lapointe, D Spiegelman… - Human genetics, 2011 - Springer
Growing genetic evidence is converging in favor of common pathogenic mechanisms for
autism spectrum disorders (ASD), intellectual disability (ID or mental retardation) and …

[PDF][PDF] Direct measure of the de novo mutation rate in autism and schizophrenia cohorts

…, AR Griffing, M Côté, E Henrion, D Spiegelman… - The American Journal of …, 2010 - cell.com
The role of de novo mutations (DNMs) in common diseases remains largely unknown.
Nonetheless, the rate of de novo deleterious mutations and the strength of selection against de …